Price
463
-2.64%52W Range
Market Cap
₹17,712.86 Cr
Traded: ₹76.15 Cr (0.43%) 0.0x
Free Float: ₹2,640.99 Cr (2.88% of FF traded)
Volume · 60D trend
16.39 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +8.0% | -3.0% | -- | +23.0% | Stable |
| Return | -- | -10.0% | -16.0% | -76.0% | -- | Decelerating |
| Profit | -- | -5.0% | -16.0% | -- | -28.0% | Decelerating |
| ROE | -- | +21.0% | +17.0% | -- | -- | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 422 | 619 | 545 | 556 | 549 | 840 | 676 | 604 | 488 | 253 | 220 | 231 | 348 | 369 | 354 | 278 |
| Expenses | 421 | 520 | 449 | 435 | 437 | 611 | 439 | 398 | 363 | 180 | 154 | 133 | 181 | 198 | 207 | 179 |
| Operating Profit | 1 | 99 | 95 | 121 | 112 | 229 | 237 | 205 | 125 | 73 | 66 | 98 | 167 | 172 | 147 | 100 |
| OPM % | 0.3% | 16.0% | 18.0% | 22.0% | 20.0% | 27.0% | 35.0% | 34.0% | 26.0% | 29.0% | 30.0% | 42.0% | 48.0% | 46.5% | 41.0% | 36.0% |
| Other Income | 12 | -18 | 1 | 16 | 6 | -4 | 22 | 16 | 19 | 17 | 14 | 20 | 11 | 11 | 13 | 11 |
| Interest | 7 | 9 | 9 | 9 | 10 | 10 | 11 | 10 | 10 | 2 | 2 | 0 | 1 | 5 | 1 | 0 |
| Depreciation | 50 | 51 | 47 | 44 | 45 | 54 | 44 | 38 | 31 | 17 | 13 | 12 | 13 | 12 | 12 | 12 |
| Profit Before Tax | -43 | 20 | 41 | 84 | 63 | 161 | 205 | 174 | 103 | 71 | 65 | 105 | 164 | 166 | 146 | 98 |
| Tax % | 5.0% | 58.0% | 29.0% | 21.0% | 26.0% | 27.0% | 25.0% | 21.0% | 27.0% | 25.0% | 29.0% | 25.0% | 26.0% | 25.4% | 26.0% | 27.0% |
| Net Profit | -45 | 8 | 29 | 66 | 46 | 117 | 153 | 138 | 75 | 53 | 47 | 80 | 121 | 124 | 108 | 72 |
| Exceptional Items | -- | -17 | -5 | 0 | -8 | -16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | -0.6 | 0.5 | 1.0 | 1.9 | 1.3 | 4.7 | 6.0 | 5.4 | 3.0 | 2.1 | 1.8 | 3.1 | 4.7 | 4.9 | 4.2 | 2.8 |
| Sales Growth (YoY) | -- | -26.3% | -19.5% | -8.0% | 12.6% | 232.3% | 207.6% | 161.3% | 40.4% | -31.5% | -37.9% | -17.0% | 2.6% | 1.5% | -- | -- |
| Sales Growth (QoQ) | -- | 13.7% | -2.0% | 1.1% | -34.6% | 24.3% | 12.0% | 23.7% | 93.0% | 15.1% | -4.9% | -33.5% | -5.9% | 4.3% | 27.3% | -- |
| OP Growth (YoY) | -99.1% | -56.8% | -59.9% | -41.0% | -10.4% | 213.7% | 259.1% | 109.2% | -25.1% | -57.5% | -55.1% | -2.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | -99.0% | 4.2% | -21.5% | 8.0% | -51.1% | -3.4% | 15.6% | 64.0% | 71.2% | 10.6% | -32.7% | -41.3% | -2.8% | 16.9% | 47.0% | -- |
| Profit Growth (YoY) | -- | -87.0% | -74.0% | -46.0% | -28.0% | 147.0% | 227.0% | 74.0% | -38.0% | -57.0% | -57.0% | 10.0% | 12.0% | 35.0% | -33.0% | -26.0% |
| EPS Growth (YoY) | -- | -89.2% | -84.0% | -64.3% | -56.8% | 125.2% | 226.6% | 73.8% | -37.5% | -56.9% | -56.5% | 10.6% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -46.9% | -50.5% | 51.6% | -72.9% | -21.3% | 10.5% | 83.8% | 41.0% | 14.1% | -41.2% | -34.0% | -2.7% | 15.1% | 49.5% | -- |
| OP Margin | -- | 15.9% | 17.5% | 21.8% | 20.4% | 27.3% | 35.1% | 34.0% | 25.6% | 29.0% | 30.1% | 42.4% | 48.0% | 46.5% | 41.5% | 36.0% |
| Net Margin | -- | 1.3% | 5.3% | 11.9% | 8.4% | 13.9% | 22.7% | 22.9% | 15.4% | 21.1% | 21.3% | 34.4% | 34.7% | 33.6% | 30.5% | 25.9% |
| Material Cost % | -- | 34.6% | 29.2% | 25.4% | 27.0% | 35.7% | 27.9% | 28.7% | 31.6% | 33.1% | 33.0% | 24.9% | 29.1% | 31.5% | 31.0% | 30.9% |
| Employee Cost % | -- | 20.8% | 21.8% | 22.8% | 24.3% | 16.5% | 16.5% | 16.9% | 19.6% | 15.6% | 15.8% | 12.4% | 8.3% | 7.5% | 8.4% | 10.3% |
| P/S | 8.27 | 7.24 | 7.45 | 5.27 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 166.55 | 91.57 | 54.39 | 27.65 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 4.53 | 4.20 | 4.90 | 3.13 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Credit Rating
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd
Earnings Call Transcript
Newspaper Publication
Outcome of the Board Meeting
Outcome of the Board Meeting
Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Allotment of Equity Shares pursuant to exercise of Stock Options and grant of Stock Options to certain eligible employees of the Company
Results Conference Call
Compliance Certificate under 74(5) of SEBI (DP) Regulations 2018
Newspaper Publication
Closure of Trading Window
The Exchange has sought clarification from Cohance Lifesciences Ltd on June 24, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited.
Clarification on Volume Movement
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CSC Global Capital Markets (Singapore) Pte Ltd
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 17, 2026 for Jusmiral Holdings Ltd & Others
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 17, 2026 for Jusmiral Holdings Ltd & Others
Resignation of Mr. Himanshu Agarwal as Executive Director and Chief Financial Officer of the Company
Postal Ballot outcome and voting results
Postal Ballot Scrutinizer''s Report
Investors Meet
Annual Secretarial Compliance Report
Investors Meet
Newspaper Publication
Earnings Call Transcript
Notice of Postal Ballot
Newspaper Publication
Investors Meet
Outcome of the Board Meeting
Outcome of the Board Meeting
Audio of Conference Call
Cohance Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 ,inter alia, to consider and approve the Audited Financial ....
Schedule of Conference Call for Investors and analysts
Clarification on Movement in Price of Equity Shares
The Exchange has sought clarification from Cohance Lifesciences Ltd on April 29, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Outcome of the Board Meeting
Press Release
Brief profile of Mr. Umang Vohra, Chairman and Group CEO
The Exchange has sought clarification from Cohance Lifesciences Ltd on April 13, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
Clarification with respect to Volume Movement
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
Appointment of Mr. Sisir K. Mishra as Company Secretary and Compliance Officer of the Company
Closure of Trading Window
Grant of Stock Options
Investors Meet
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasti Property & Equity Holdings Pvt Ltd & Others
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasub Property Holdings LLP & PACs
Annual Reports
6Credit Ratings
6Concalls
36Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jun 2025
30 Jun 2025Feb 2025
28 Feb 2025Jan 2025
31 Jan 2025Dec 2024
31 Dec 2024Dec 2024
31 Dec 2024Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Jun 2024
30 Jun 2024Jun 2024
30 Jun 2024Mar 2024
31 Mar 2024Feb 2024
29 Feb 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023Feb 2023
28 Feb 2023Dec 2022
31 Dec 2022Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Jun 2022
30 Jun 2022May 2022
31 May 2022May 2022
31 May 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Feb 2021
28 Feb 2021Dec 2020
31 Dec 2020Oct 2020
31 Oct 2020Aug 2020
31 Aug 2020Jun 2020
30 Jun 2020Held by ETFs
16 ETFs hold COHANCE · sorted by weight
Held by Mutual Funds
60 schemes hold COHANCE · sorted by weight